Patent ID: 6024980
Filing Date: 2000-02-15
Classification: A61K,A61P

Abstract:
A pharmaceutical dosage form, comprising:a gelatin capsule shell;a first phase comprising a first semi-solid containing a polyalkylene glycol having an average molecular weight of about 600 or less and a cellulose ether in an amount effective to thicken the polyalkylene glycol, a therapeutically effective amount of a first pharmaceutical dissolved or suspended in said first semi-solid and said first semi-solid having a turbidity less than about 1300 NTU;a second phase comprising a second semi-solid fill containing a polyalkylene glycol having an average molecular weight of about 400 to about 20,000 and a therapeutically effective amount of a second pharmaceutical disposed in said semi-solid; andsaid first and second phases each disposed in discrete regions of said shell and in contact with each other at at least one interface.